top of page
TheraNest
Technology
Saas Platforms
Healthcare IT Mental/Behavioral Health Practice Management
Won by pricing itself around active client caseload rather than clinician headcount, making it the structurally cheaper choice for solo and small practices with many part-time clients -- until a private-equity rollup rebrand blurred that exact advantage.
1
MODEL
BUSINESS MODEL
SaaS
model bm
HOW THEY BUILT IT
- Founded 2013 in Birmingham, Alabama, by Shegun Otulana, growing into one of the most widely used practice-management tools specifically for outpatient mental and behavioral health, competing directly with SimplePractice and TherapyNotes.
- Built a genuinely distinctive pricing structure -- charging by active client caseload size (five tiers: up to 30 clients, 30-39, 40-49, 50-79, 80+) rather than by number of clinicians, letting practices add practitioners at no extra cost as long as caseload stayed within a tier.
- Acquired by Therapy Brands (a private-equity-backed healthcare software roll-up, later under KKR ownership) and, as of April 2025, rebranded from TheraNest to 'Ensora Mental Health' -- a rebrand that also came with a fundamental pricing-model shift from per-client to per-therapist pricing.
- Reached HITRUST certification and full HIPAA/ONC compliance, serving solo practitioners, group practices, and nonprofit/educational behavioral health organizations at scale, with 1,000+ verified reviews reflecting broad market adoption.
HOW TO ARCHITECT IT
1. Identify the one pricing dimension that structurally favors your target underserved segment versus how competitors price, because a genuinely different pricing axis can be a real acquisition advantage, not just a marketing angle.
2. Let a practice add clinicians at no additional cost within a caseload tier, because it removes a common growth-penalty friction point that per-seat competitors impose, making your product the obvious choice as a practice scales its team.
3. Build deep customization (a Dynamic Forms builder) as a genuine differentiator for practices with idiosyncratic workflows, accepting the learning-curve tradeoff, because flexibility retains sophisticated customers a more rigid competitor would lose.
4. If acquired into a larger private-equity-backed portfolio, recognize that changing your core pricing model and rebranding simultaneously risks alienating the exact price-sensitive customers your original model was built to serve -- protect the founding differentiator, or be explicit with customers about why it's changing.
DISTRIBUTION MODEL
Self-Serve Website, Content Distribution
dm
HOW THEY OPERATIONALIZED
- Self-serve signup with a 21-day free trial, letting solo practitioners and small practices evaluate the platform before committing.
- Nonprofit discount program (25% off base subscription) specifically targeting community mental health organizations and educational institutions.
- Word-of-mouth and switching behavior driven by individual clinicians who used TheraNest as an employee at one organization, then brought it with them when opening or joining a private practice.
HOW TO REPLICATE WHAT WORKED
What worked: the caseload-based, not-per-clinician pricing model directly targeted solo and small practices, and clinicians who used the tool as an employee often chose to bring it into their own private practice later -- an organic, trust-based growth loop built on individual clinician familiarity.
The trap: pricing based on caseload size, while attractive to small practices, becomes comparatively expensive for larger, high-volume group practices -- exactly the segment TheraNest's post-acquisition per-therapist pricing shift seems designed to capture instead, at the cost of alienating the smaller practices the original model favored.
| PATTERNS OF THIS MODEL
PATTERNS IN PRICING-AXIS DIFFERENTIATION AND WHAT ACQUISITION DOES TO IT:
1. CHOOSE THE PRICING DIMENSION THAT STRUCTURALLY FAVOURS YOUR SEGMENT. A different axis is an acquisition advantage, not a marketing angle.
2. REMOVING THE GROWTH PENALTY WINS SCALING CUSTOMERS. Per-seat rivals tax expansion; you become obvious precisely when the customer grows.
3. DEEP CUSTOMISATION RETAINS SOPHISTICATED CUSTOMERS at the cost of a steeper learning curve — an acceptable trade when rigid rivals lose them anyway.
4. A PORTFOLIO OWNER WILL EVENTUALLY NORMALISE YOUR PRICING MODEL. If a distinctive model is your moat, price that risk into any sale.
What companies with this model reveal
| OPPORTUNITY INTELLIGENCE
GOLDMINE 1 — FIND THE PRICING AXIS THAT FAVOURS YOUR SEGMENT.
Standard: charging by caseload rather than clinician let practices add staff free. A different pricing dimension is an acquisition advantage, not a marketing angle.
GOLDMINE 2 — REMOVE THE GROWTH PENALTY RIVALS IMPOSE.
Standard: be the obvious choice at the exact moment the customer is scaling.
GOLDMINE 3 — DEEP CUSTOMISATION RETAINS SOPHISTICATED PRACTICES.
THE PIT — CHANGING THE FOUNDING DIFFERENTIATOR AND THE BRAND AT ONCE.
The 2025 Ensora rebrand shipped alongside a shift from per-client to per-therapist pricing — abandoning the exact advantage that acquired price-sensitive customers, at the moment they lost the name they recognised. Separate the two and explain the second, or it reads as extraction.
THE SECOND PIT — PE ROLL-UP OWNERSHIP SETS PRICING BY PORTFOLIO LOGIC.
MOVE WITH CAUTION — A PRICING SHOCK IS THE ONE EVENT THAT MAKES A CLINICIAN ENDURE A MIGRATION.
Untapped Business Model / Gaps / Goldmines / Pits
Patterns & Insights
2
MARKET
mkt mt es
MARKET TYPE
Fragmented Market
WHY THEY WON
Mental and behavioral health practice-management software is fragmented among several credible platforms (SimplePractice, TherapyNotes, Valant, Osmind), each with slightly different pricing models and feature emphases. TheraNest won its niche specifically among small, non-profit, and low-caseload-per-clinician practices by pricing on caseload rather than headcount. Transferable principle: in a fragmented market where competitors have converged on the same pricing axis, pricing on a genuinely different axis that favors an underserved buyer segment can carve out real share.
ENTRY STRATEGY
Greenfield Entry
EXECUTION
TheraNest was built directly by founder Shegun Otulana as a standalone practice-management platform rather than through acquisition of an existing tool, evidenced by its 2013 founding and organic growth into direct competition with SimplePractice and TherapyNotes before its own later acquisition by Therapy Brands.
FOOTHOLD STRATEGY
fs
Beachhead Strategy
The initial foothold was solo practitioners and small group practices, plus nonprofit and educational behavioral health organizations, who needed an affordable, HIPAA-compliant system priced favorably for their caseload structure; from that beachhead, TheraNest expanded into larger, multi-location behavioral health organizations as its billing, compliance, and reporting features matured.
GROWTH CAMPAIGN
CAMPAIGNS THAT WORKED
Case studies and reviews emphasizing cost-effectiveness specifically for nonprofit and educational institutions managing diverse, often-fluctuating caseloads; word-of-mouth driven by clinicians who used TheraNest at one employer and then brought the familiar tool into their own subsequent private practice; the Wiley Practice Planners integration used as a credibility and time-saving differentiator against competitors lacking it.
KEY LEARNING
If your buyer segment includes nonprofit or budget-constrained organizations, an explicit nonprofit discount and a pricing axis that rewards their specific structure can be a meaningful acquisition lever competitors ignore. If clinicians in your category frequently move between employment and private practice, optimize for that individual's familiarity carrying over -- a satisfied user at one organization is a future customer once they open their own practice.
gc
Market Context
| MARKET INTELLIGENCE
THE STANDARD: Where competitors converge on one pricing axis, pricing on a different axis that favours an underserved segment carves out real share.
RULE 1 — PRICE ON THE UNIT YOUR UNDERSERVED BUYER ACTUALLY VARIES ON. Per-clinician pricing punishes agencies with many part-time or low-caseload staff.
RULE 2 — NON-PROFIT BUYERS HAVE DISTINCT REQUIREMENTS, NOT JUST SMALLER BUDGETS. Grant reporting, supervision hierarchies and sliding-scale billing are not solo-practitioner features.
RULE 3 — CLAIMS PROCESSING IS THE DEFENSIBLE LAYER. Reimbursement determines whether the practice survives.
RULE 4 — EVERY ROLL-UP CREATES DEMAND FOR AN INDEPENDENT ALTERNATIVE. Consolidation reliably manufactures your competitor's positioning.
MARKET TYPE: Fragmented Market (behavioural health practice management).
| MARKET ENTRY PLAYBOOK
THE STANDARD: A CROWDED VERTICAL WITH NO DOMINANT PLAYER REWARDS PRICE-ACCESSIBLE ENTRY AND ENDS IN CONSOLIDATION — plan to be a buyer or a seller.
RULE 1 — ENTER BENEATH THE INCUMBENTS ON PRICE FOR SMALL PRACTICES.
Solo and small behavioural health practices are numerous, underserved and self-serve reachable. Low price is the entry; it is not a position.
RULE 2 — COMPLIANCE AND NOTE TEMPLATES ARE THE SWITCHING COST.
Years of clinical records under a specific format is what makes migration a risk decision.
RULE 3 — FRAGMENTED HEALTH VERTICALS ARE ROLL-UP INVENTORY.
Predictable renewals plus small scale is exactly what platform acquirers price; the exit is usually a portfolio, not an IPO.
EVIDENCE: founded 2013 by Shegun Otulana as a standalone practice-management platform competing with SimplePractice and TherapyNotes; acquired by Therapy Brands, subsequently backed by KKR. Deal terms and revenue undisclosed.
How to enter
| FOOTHOLD STRATEGY PLAYBOOK
THE STANDARD: NON-PROFIT AND EDUCATIONAL ORGANISATIONS ARE A DISTINCT PRICING SEGMENT WITH DISTINCT REPORTING NEEDS. Serving them deliberately is an underused vertical wedge.
RULE 1 — PRICE ON THE UNIT THE ORGANISATION ACTUALLY VARIES. Behavioural health organisations differ enormously in active caseload; pricing that flexes with caseload rather than seats fits how they are funded.
RULE 2 — GRANT AND FUNDER REPORTING IS AN UNDERSERVED REQUIREMENT. Non-profits must report outcomes to funders in formats commercial EHRs never produce — that is a defensible niche inside a crowded category.
RULE 3 — COMPLIANCE IS THE ENTRY TICKET, NOT THE DIFFERENTIATOR. Every competitor is HIPAA-compliant; the differentiation is billing accuracy and reporting fit.
RULE 4 — SMALL BEHAVIOURAL HEALTH SOFTWARE COMPANIES ARE ROLL-UP TARGETS. The vertical has been consolidated aggressively by private equity buying multiple point products.
EVIDENCE: The initial foothold was solo practitioners, small group practices, and non-profit and educational behavioural health organisations needing an affordable, HIPAA-compliant system priced for their caseload structure, expanding into larger multi-location organisations. TheraNest became part of Therapy Brands, which KKR acquired in 2021 in a deal reported around $1.2B; that figure was reported rather than officially confirmed, and TheraNest's standalone revenue was never disclosed.
How to get the first strong position
MARKET PATTERNS & PLAYBOOK
3
MONEY
money rev pri
REVENUE MODEL
Subscription
PRICING MODEL
Tiered Pricing
WHY THEY WON
Originally a tiered monthly/annual subscription priced by active client caseload size with unlimited clinicians included per tier; post-acquisition, shifted to a per-therapist pricing structure (Essentials ~$29/therapist/month, Advanced ~$59/therapist/month, Premier ~$89/therapist/month) more comparable to competitors -- a founder can replicate the original model specifically when targeting solo/small practices with many part-time or low-session-frequency clients.
Original caseload-based tiers meant the same core feature set was available at every tier, with price driven purely by client volume rather than feature-gating -- a structure that rewarded practices for staying lean on caseload rather than clinician count; the post-rebrand per-therapist tiers instead gate features more conventionally by plan level.
TARGET AUDIENCE
CUSTOMER BUYING BEHAVIOUR
tg cb
Solo mental health practitioners and small group practices managing variable caseloads; nonprofit and educational behavioral health organizations needing HIPAA-compliant, budget-conscious practice management; larger, multi-location behavioral health organizations needing multi-provider caseload management and compliance reporting.
Self-serve trial-to-paid for solo and small practices, often driven by prior familiarity from clinical employment elsewhere; larger organizations pursue a more considered, feature- and compliance-driven evaluation process, increasingly weighing TheraNest/Ensora against competitors amid reported post-acquisition slowdowns in product development and support responsiveness.
| PRICING INTELLIGENCE
What makes this model effective & make customers pay
THE STANDARD: In small clinical practices, price per clinician and keep it under the value of a single session. Above that line, the subscription becomes a monthly deliberation.
RULE 1 — TIER ON ACTIVE CLIENT VOLUME, WHICH IS THE PRACTICE'S OWN REVENUE UNIT.
The fee rises only as the practice grows, so every increase feels earned.
RULE 2 — INSURANCE CLAIM ACCEPTANCE IS THE HIGHEST-VALUE FUNCTION.
A rejected claim is work already performed and unpaid. Anything raising acceptance rates is priced against revenue rather than admin.
RULE 3 — COMPLIANCE REQUIREMENTS REMOVE THE FREE ALTERNATIVE ENTIRELY.
Clinicians cannot keep client notes in consumer tools. Regulation converts discretionary spend into required spend.
RULE 4 — CONSOLIDATION IS THE CATEGORY'S DIRECTION, AND IT CHANGES PRICING.
Behavioural health practice management has consolidated under larger owners. Expect packaging changes and add-on unbundling after ownership changes — the standard pattern.
THE WILLINGNESS-TO-PAY INSIGHT: A therapist is buying the ability to be paid correctly and stay compliant without hiring an administrator. Both are anxieties rather than efficiencies, and anxiety sustains renewals that convenience never does.
PRICE & REVENUE
| Revenue Risk - The biggest threat to revenue stability
Repricing an installed base from one model to another is the most churn-inducing move in SaaS, and it targets exactly the customers who chose you for the old model.
Converging on the category norm forfeits your differentiation while keeping all the migration cost.
Inside a PE roll-up, overlapping products mean eventual consolidation is the base case, not a risk.
Small healthcare practices are exposed to reimbursement policy that determines whether their business works at all.
Pricing moved from caseload-based with unlimited clinicians to per-therapist tiers post-acquisition; no revenue or churn published.
Where the model can break
4
MOTION
(TheraNest now operates under the Ensora Health / Ensora Mental Health brand; verify current social handles before use)
GROWTH EXPANSION MODEL
COMPETITIVE STRATEGY
motion ge cs
Product Line Expansion, Ecosystem Expansion
HOW THEY EXPAND
The sequence: core scheduling, notes, and billing platform (2013-2018), expansion into telehealth, e-prescribing, and a client portal as compliance and remote-care needs grew, then acquisition by Therapy Brands and integration into a broader multi-product healthcare software portfolio, culminating in the April 2025 rebrand to Ensora Mental Health alongside a shift to per-therapist pricing and new AI features -- moving from an independent, caseload-priced niche product into one branded product within a larger consolidated healthcare software company.
Differentiation
HOW THEY COMPETE
TheraNest differentiated primarily through its caseload-based pricing model and deep forms/documentation customization rather than competing directly on ease-of-use polish with SimplePractice or structured rigidity with TherapyNotes -- appealing specifically to practices that valued flexibility and cost-efficiency for their particular caseload structure.
GROWTH ENGINE
GTM
ge n gtm
Freemium User Acquisition, Referral Loops
A generous free trial and low entry-tier pricing let solo practitioners try the platform with minimal commitment, while clinicians who first encountered TheraNest as employees elsewhere often become the referral mechanism when they later open or join a private practice; the loop has weakened somewhat post-acquisition, per user reports of slower support response times and product development redirected toward consolidating the broader Therapy Brands/Ensora portfolio.
Content marketing and reviews targeting solo practitioners and nonprofit behavioral health organizations specifically; free trial-driven self-serve conversion; word-of-mouth from clinicians carrying platform familiarity from employment into their own private practice; more recently, AI-feature announcements used to signal continued innovation post-acquisition.
SUSTAINING MOATS
Switching Costs, High Customer Lock-In, Brand Power, Technology Advantage (complex enterprise scenarios)
moat
Practices that have built years of client records, custom forms, and billing history inside TheraNest face real data-migration and retraining costs to leave, a switching cost reinforced by HITRUST/HIPAA/ONC compliance credentialing a new vendor would need to re-establish trust around; however, the moat is currently under some strain, as the 2025 rebrand and pricing change appear to have introduced genuine customer confusion that a more stable competitor could exploit.
| MOAT INTELLIGENCE
THE STANDARD: Inside a healthcare roll-up, a product's moat is its clinical specialisation and its risk is that the parent decides one platform should serve every specialty.
RULE 1 — SPECIALTY-SPECIFIC WORKFLOW IS WHY SMALL PRACTICES STAY. Treatment plans, progress notes, assessment instruments and billing codes differ materially by discipline. A general product serves none of them well.
RULE 2 — OVERLAPPING PORTFOLIO PRODUCTS EVENTUALLY CONVERGE. When one owner holds several products serving adjacent specialties, consolidation is the standard efficiency play — and it arrives as a migration notice, not a strategy announcement.
RULE 3 — CLINICAL DOCUMENTATION IS RETAINED FOR YEARS BY LAW, so migration means moving records with statutory retention obligations attached. That is a compliance project, not a data export.
THE SIGNAL: when several products serving the same buyer sit under one owner, identify which one the parent is investing in. That answer determines whether the vendor relationship is a partnership or a countdown.
Why this company remains defensible
ARR & TAKEAWAY
ARR Journey - what to do at each stage
PRE-$1M ARR — BUILD FOR THE SMALL BEHAVIOURAL-HEALTH PRACTICE
Solo and small mental-health practices are numerous, compliance-bound and underserved by hospital EHRs.
Notes, scheduling, billing and a client portal in one product — they will not assemble a stack.
$1–5M ARR — INSURANCE CLAIMS ARE THE REAL PRODUCT
Getting reimbursed is harder than documentation and worth far more. Build claims properly or stay a notes tool.
WATCH: claims submitted and first-pass acceptance rate.
$5–10M ARR — TELEHEALTH AND COMPLIANCE ARE TABLE STAKES
HIPAA-correct video and records are the entry requirement, not a differentiator.
$10–50M ARR — ROLL-UP ECONOMICS TAKE OVER
Behavioural health software consolidated quickly. TheraNest sits within the Therapy Brands portfolio, which was acquired by KKR in 2021 in a transaction reported at roughly $1.2B.
Under platform ownership, cross-sell and payments attach become the targets.
$50–100M ARR — MIGRATION RISK IS THE MAIN CHURN DRIVER
Consolidating acquired products into one platform produces customer-visible migrations. Sequence them away from renewals.
NOTE: standalone ARR is not disclosed.
$100M+ ARR — NOT AS A STANDALONE
Rule: in clinical verticals the payments and claims layer is the business, and the roll-up is the destination. Build to be integrated cleanly.
COPY PLAYBOOK : What Worked → What Failed → What to Replicate → What to Avoid
THE STANDARD: Pricing on volume rather than headcount wins small customers — and creates the exact segment tension a new owner will resolve against them.
SEQUENCE:
1. Price on the customer's actual scale so a small buyer pays small.
2. Let professionals who use it as employees carry it into their own practices later.
3. Attach the hardest workflow step for durable lock-in.
WORKED: A trust-based growth loop where today's employee user is tomorrow's owner-buyer.
CAUTION:
1. VOLUME PRICING BECOMES EXPENSIVE FOR LARGE CUSTOMERS — and the post-acquisition shift to headcount pricing captures them at the cost of alienating the base the original model was built for.
2. RE-PRICING A LOYAL BASE AFTER ACQUISITION IS THE MOST RELIABLE WAY TO MANUFACTURE PUBLIC BACKLASH.
bottom of page